Estimated Control Closed Transaction verified BiopharmaceuticalsBiotechFood Allergy TherapeuticsPeanut Allergy TherapyTherapeutics
Aimmune Therapeutics acquired by Sociétés des Produits Nestlé S.A. / Nestlé Health Science
Sociétés des Produits Nestlé S.A. / Nestlé Health Science acquired Aimmune Therapeutics, a US therapeutics brand, on Aug 31, 2020.
Transaction summary
- Target
- Aimmune Therapeutics
- Acquirer
- Sociétés des Produits Nestlé S.A. / Nestlé Health Science
- Seller
- -
- Announced
- 2020-08-31
- Geography
- United States
- Tags
- BiopharmaceuticalsBiotechFood Allergy TherapeuticsPeanut Allergy TherapyTherapeutics
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-08-08
- Latest update
- 2026-08-08
Value and multiples
Price / value
USD 2.6B
Transaction value | USD
Basis: Public source
Price / revenue
-
Period not stated
Basis: FundComb estimate
Price / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Basis
- USD 2.6bn transaction value is treated as publicly disclosed or derived directly from public source data.
Source summary
No public source summary has been published for this transaction yet.